These outcomes, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the strategy of concentrating on ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. Disclaimer: The above can https://catmanb258ogc5.blogdomago.com/profile